Experimental Alzheimer’s drug slows cognitive decline in trial
MELBOURNE: An experimental Alzheimer’s drug slowed cognitive and functional decline by 27 percent in a
MELBOURNE: An experimental Alzheimer’s drug slowed cognitive and functional decline by 27 percent in a
FEATURED
Construction loan now secured for innovative seniors community
Senior living operators plan more moderate rental rate growth
10-storey apartments under 1500-home plan around golf course
High rise living above casino pitched to boomer market
Pilot study to improve staff interactions with residents with dementia
Senior living marketing leaps into digital age with innovations
INNOVATION
